VMI

VHCP Management II Portfolio holdings

AUM $379M
This Quarter Return
+37.65%
1 Year Return
+424.39%
3 Year Return
+2,335.22%
5 Year Return
–
10 Year Return
–
AUM
$362M
AUM Growth
+$362M
Cap. Flow
+$61.4M
Cap. Flow %
16.96%
Top 10 Hldgs %
91.12%
Holding
24
New
5
Increased
3
Reduced
3
Closed
3

Top Buys

1
ZGNX
Zogenix, Inc.
ZGNX
$31.8M
2
MYOK
MyoKardia, Inc. Common Stock
MYOK
$11.4M
3
ASND icon
Ascendis Pharma
ASND
$11.3M
4
OBSV
ObsEva SA Ordinary Shares
OBSV
$10.2M
5
ANAB icon
AnaptysBio
ANAB
$5.86M

Top Sells

1
PDSB icon
PDS Biotechnology
PDSB
$7.02M
2
XLRN
Acceleron Pharma Inc.
XLRN
$4.77M
3
CTMX icon
CytomX Therapeutics
CTMX
$4.48M
4
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
$1.55M
5
OCRX
Ocera Therapeutics, Inc.
OCRX
$844K

Sector Composition

1 Healthcare 92.37%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
AVXS
1
DELISTED
AveXis, Inc. Common Stock
AVXS
$100M 27.68% 1,035,657 – –
BHVN
2
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$60.8M 16.81% 1,664,300 – –
ASND icon
3
Ascendis Pharma
ASND
$11.8B
$47.1M 13.01% 1,299,052 +312,560 +32% +$11.3M
ZGNX
4
DELISTED
Zogenix, Inc.
ZGNX
$31.8M 8.78% +907,057 New +$31.8M
BCRX icon
5
BioCryst Pharmaceuticals
BCRX
$1.74B
$16.6M 4.58% 3,165,457 +690,290 +28% +$3.62M
ARGX icon
6
argenx
ARGX
$43.6B
$14.5M 4% 647,015 – –
PDSB icon
7
PDS Biotechnology
PDSB
$57.8M
$13.7M 3.79% 1,279,267 -654,315 -34% -$7.02M
OBSV
8
DELISTED
ObsEva SA Ordinary Shares
OBSV
$11.4M 3.15% 1,401,343 +1,251,343 +834% +$10.2M
MYOK
9
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$11.4M 3.14% +265,000 New +$11.4M
RARX
10
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$11.2M 3.11% 769,771 – –
ANAB icon
11
AnaptysBio
ANAB
$569M
$5.86M 1.62% +167,550 New +$5.86M
BLPH
12
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$4.72M 1.3% +4,149,378 New +$4.72M
AKTX
13
Akari Therapeutics
AKTX
$24.8M
$2.62M 0.72% 426,297 – –
LPCN icon
14
Lipocine
LPCN
$15.8M
$1.54M 0.42% 386,928 – –
KALV icon
15
KalVista Pharmaceuticals
KALV
$678M
$1.49M 0.41% 221,651 – –
MDGL icon
16
Madrigal Pharmaceuticals
MDGL
$9.76B
$1.35M 0.37% +30,000 New +$1.35M
ORKA
17
Oruka Therapeutics, Inc. Common Stock
ORKA
$554M
$1.24M 0.34% 1,078,932 – –
ADVM icon
18
Adverum Biotechnologies
ADVM
$64.6M
$1.02M 0.28% 280,000 – –
OCRX
19
DELISTED
Ocera Therapeutics, Inc.
OCRX
$544K 0.15% 477,269 -740,603 -61% -$844K
SIOX
20
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$524K 0.14% 76,162 -225,556 -75% -$1.55M
CTMX icon
21
CytomX Therapeutics
CTMX
$336M
– – -288,915 Closed -$4.48M
SRRA
22
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
– – -130,798 Closed -$153K
XLRN
23
DELISTED
Acceleron Pharma Inc.
XLRN
– – -156,880 Closed -$4.77M